| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
ORIGINAL ARTICLE |
1 School of Nursing and Midwifery Studies, University of Wales College of Medicine, Cardiff, UK
2 Institute of Medical Genetics, University of Wales College of Medicine
3 Division of General Practice, University of Wales College of Medicine
4 Family and Child Psychology Research Centre, City University, London, UK
5 Department of Medical Biochemistry, University Hospital of Wales, Cardiff, UK
Correspondence to:
Correspondence to:
Dr Parsons, School of Nursing and Midwifery Studies, UWCM, Heath Park, Cardiff CF14 4XN, Wales, UK;
parsonsep{at}cardiff.ac.uk
Objective: To evaluate the psychosocial implications of newborn screening for Duchenne muscular dystrophy.
Design: Prospective psychosocial assessment.
Setting: Primary care.
Respondents: Study: (a) families of an affected boy identified by screening (n = 20); (b) families of a boy with a transient screening abnormality (n = 18). Control: (a) families of a boy with a later clinical diagnosis (n = 16); (b) random sample of mothers of boys aged 6–9 months (n = 43).
Interventions: Questionnaires and semistructured interviews.
Main outcome measures: Attitudes to newborn screening and impact of screening on mother-baby relationship, anxiety/wellbeing, and reproductive patterning within families of an affected boy.
Results: Most families of an affected boy were in favour of newborn screening on the grounds of reproductive choice and time to prepare emotionally and practically. There was no evidence of any long term disruption to the mother-baby relationship. Anxiety levels for the screened group were slightly above threshold but returned to normal during the period of the study. There was no evidence, from anxiety or wellbeing scores, that the transient group had suffered any disadvantage. Although the profile of the screened and later clinically diagnosed cohorts was similar after diagnosis, when boys from the screened cohort were 4 years old and more socially aware, their profile was more positive. There was evidence that reproductive patterning had been modified, and four fetuses carrying a mutation causing Duchenne muscular dystrophy were terminated.
Conclusion: A case can be made for newborn screening provided that the test is optional, a rigorous protocol for service delivery is used, and an infrastructure providing continuing support is in place.
Keywords: screening; Duchenne muscular dystrophy; psychosocial genetics
This article has been cited by other articles:
|
|
 |
|
  M. Downing and R. Pollitt Newborn bloodspot screening in the UK - past, present and future Ann Clin Biochem, January 1, 2008; 45(1): 11 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Kerruish, P. L. Campbell-Stokes, A. Gray, T. R. Merriman, S. P. Robertson, and B. J. Taylor Maternal Psychological Reaction to Newborn Genetic Screening for Type 1 Diabetes Pediatrics, August 1, 2007; 120(2): e324 - e335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Acharya, P. D. Ackerman, and L. F. Ross Pediatricians' Attitudes Toward Expanding Newborn Screening Pediatrics, October 1, 2005; 116(4): e476 - e484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N J Kerruish and S P Robertson Newborn screening: new developments, new dilemmas J. Med. Ethics, July 1, 2005; 31(7): 393 - 398. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| ARCH DIS CHILD | FETAL NEONATAL ED | ED PRACTICE |
